Ward Amy, Graham Siobhan, Almond Ewan, Withers Dom
Oncology, Queen's Hospital, BHRUT (Barking, Havering and Redbridge University Hospitals NHS Trust), Romford, GBR.
Radiotherapy, Queen's Hospital, BHRUT (Barking, Havering and Redbridge University Hospitals NHS Trust), Romford, GBR.
Cureus. 2024 Oct 7;16(10):e70971. doi: 10.7759/cureus.70971. eCollection 2024 Oct.
We present a case of a patient having cone-beam CT (CBCT)-based online adaptive radiotherapy (oART) on Ethos Therapy after oesophagectomy and gastric pull-up. This case report aims to demonstrate that daily oART is a viable treatment option for post-oesophagectomy patients. The patient's radiotherapy plan was generated on the Ethos system using an eight-field intensity-modulated radiation therapy (IMRT) plan imported from the Eclipse planning system. The patient was prescribed 50.4Gy/28# over 5.5 weeks with concurrent carboplatin and paclitaxel. There were no changes to our department's standard clinical tumour volume (CTV) and planning tumour volume (PTV) margins due to the novel nature of the case. For each fraction of daily oART, the heart, right and left lungs, oesophagus and trachea were Ethos-contoured 'Influencer' structures which were reviewed and edited at the console. Minor edits were required to each structure. The adaptive plan was chosen for each fraction due to showing clear dosimetric benefits to both PTV coverage and organ at risk (OAR) doses. Lung doses were significantly reduced with the course mean lung dose reduction of 8.1% and the Lung-CTV V20 reduction of 4.4%. The treatment duration from the start of CBCT acquisition to the end of beam delivery averaged 19 minutes and 12 seconds. The patient was able to tolerate the time on the bed without incident within the scheduled 30-minute appointment slot. Our case demonstrates that significant inter-fraction anatomy changes occur in patients having radiotherapy after oesophagectomy. Without the use of adaption, we have seen that there would be clinically significant undercoverage of target volumes due to sub-optimal dose distribution. We plan to evaluate the imaging available in Ethos dose monitoring to establish if these margins could be reduced in patients treated with online adaptive radiotherapy.
我们报告一例食管癌切除及胃上提术后患者在Ethos治疗系统上基于锥形束CT(CBCT)进行在线自适应放疗(oART)的病例。本病例报告旨在证明每日oART是食管癌切除术后患者可行的治疗选择。患者的放疗计划在Ethos系统上生成,使用从Eclipse计划系统导入的八野调强放射治疗(IMRT)计划。患者在5.5周内接受50.4Gy/28次的放疗,同时使用卡铂和紫杉醇。由于该病例的特殊性,我们科室的标准临床靶区(CTV)和计划靶区(PTV)边界未作改变。对于每日oART的每个分次,心脏、左右肺、食管和气管均为Ethos勾勒的“影响因素”结构,并在控制台进行复查和编辑。每个结构都需要进行少量编辑。由于自适应计划在PTV覆盖和危及器官(OAR)剂量方面均显示出明显的剂量学优势,因此为每个分次选择了该计划。肺部剂量显著降低,疗程平均肺剂量降低8.1%,肺CTV的V20降低4.4%。从开始采集CBCT到束流输送结束的治疗时间平均为19分12秒。患者能够在预定的30分钟预约时段内无意外地耐受床上时间。我们的病例表明,食管癌切除术后接受放疗的患者在分次间会出现显著的解剖结构变化。如果不采用自适应技术,我们已经看到由于剂量分布不理想,靶区体积会出现临床上显著的覆盖不足。我们计划评估Ethos剂量监测中可用的成像,以确定在接受在线自适应放疗的患者中是否可以缩小这些边界。